EcoDrugPlus

Ret Proto-Oncogene

Ensembl ID : ENSPEMG00000023447
Gene Symbol: RET
3 Cross references
204 Possible Orthologues:

Retinoic Acid Receptor Alpha

Ensembl ID : ENSPEMG00000010534
Gene Symbol: RARA
3 Cross references
331 Possible Orthologues:

Retinoic Acid Receptor Beta

Ensembl ID : ENSPEMG00000011795
Gene Symbol: RARB
3 Cross references
450 Possible Orthologues:

Retinoic Acid Receptor Gamma

Ensembl ID : ENSPEMG00000014599
Gene Symbol: RARG
3 Cross references
446 Possible Orthologues:

Retinoid X Receptor Alpha

Ensembl ID : ENSPEMG00000015777
Gene Symbol: RXRA
3 Cross references
244 Possible Orthologues:

Retinoid X Receptor Beta

Ensembl ID : ENSPEMG00000018454
Gene Symbol: RXRB
3 Cross references
234 Possible Orthologues:

Retinoid X Receptor Gamma

Ensembl ID : ENSPEMG00000013249
Gene Symbol: RXRG
3 Cross references
273 Possible Orthologues:

Ribosomal Protein L10a

Ensembl ID : ENSPEMG00000013589
Gene Symbol: RPL10A
3 Cross references
167 Possible Orthologues:

Ribosomal Protein L11

Ensembl ID : ENSPEMG00000009906
Gene Symbol: RPL11
3 Cross references
169 Possible Orthologues:

Ribosomal Protein L13

Ensembl ID : ENSPEMG00000010342
Gene Symbol: RPL13
3 Cross references
269 Possible Orthologues:

Ribosomal Protein L13a

Ensembl ID : ENSPEMG00000009221
Gene Symbol: RPL13A
3 Cross references
310 Possible Orthologues:

Ribosomal Protein L14

Ensembl ID : ENSPEMG00000016182
Gene Symbol: RPL14
1 Cross references
255 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).